New Program Brings Meharry Medical Students into the ‘Yale Family’
Six students were selected from Meharry Medical College, an historically Black medical school in Nashville, in a program designed by Yale School of Medicine’s Office of Diversity, Equity and Inclusion to provide them with research experience and career advancing networking opportunities. The students will work alongside Yale faculty members and residents, begin building networks, and deepen their understanding of careers paths in psychiatry, neurosurgery, and neuroscience.
WHRY Funds Study on How CBD Affects the Brain
Women’s Health Research at Yale announced funding to investigate how the presumably non-intoxicating cannabis ingredient cannabidiol (CBD) affects the brain, and if it affects women and men differently. CBD use is growing in popularity exponentially, yet the safety and effectiveness of this non-regulated category of products are unknown.
Yale Scientists Awarded $8.4M Grant to Develop Treatments for Women With Problem Drinking
Yale Department of Psychiatry scientists have been awarded a five-year, $8.4 million federal grant to establish a new research center at Yale that will develop treatments to help women with problem drinking.
Yale Study: Ketamine Disinhibits Dendrites and Enhances Calcium Signals in Prefrontal Dendritic Spines
In a study published in Nature Communications, Alex Kwan, PhD, Associate Professor of Psychiatry, and his research team found that within an hour after a mouse received ketamine, there is a substantial increase in the amount of calcium that goes into the dendritic spines for neurons in the prefrontal cortex.
Yale Review: How Brain Alterations Contribute to Suicidal Thoughts and Behaviors
How brain alterations contribute to suicidal thoughts and behaviors is the subject of a new published review of brain scanning studies by Yale and international researchers. Hilary Blumberg, MD, John and Hope Furth Professor of Psychiatric Neuroscience, and Professor of Psychiatry, in the Child Study Center and of Radiology and Biomedical Imaging at Yale, is the paper's lead and corresponding author.
Study Suggests Role for Targeting Psychological Variables in the Treatment of Opioid Use Disorder and Chronic Pain
There is a paucity of evidence-based treatments for co-occurring opioid use disorder and chronic pain. These inter-related chronic medical conditions have been central to the unfolding of the opioid crisis. A new study by researchers at Yale, Johns Hopkins, University of Bridgeport, and Western Connecticut State University published in the Journal of Clinical Psychology suggests that psychological variables are important treatment targets for co-occurring opioid use disorder and chronic pain.
Suicide is Preventable. So, How Can We Help Our Teens?
Suicide is preventable, but rates of suicide are increasing worldwide, and it is now the second leading cause of death in adolescents and young adults (unintentional motor vehicle accidents are first). Going to the emergency room may be the smartest thing these teenagers can do.Source: Yale Medicine
Yuen Awarded First PRMS-Endowed Fellowship for Child Psychiatry with Group for the Advancement of Psychiatry
Eunice Yuen, MD, PhD, a member of the Albert J. Solnit Integrated Training Program at Yale, has been named the first recipient of a Professional Risk Management Services (PRMS)-endowed fellowship in collaboration with the Group for the Advancement of Psychiatry (GAP), a think tank of leading psychiatric minds.
MOMS Partnership® Featured in NASEM Report as 'Promising Model'
The MOMS Partnership® is identified as a "Promising Model" in a report by the National Academies of Sciences, Engineering, and Medicine titled, "Vibrant and Health Kids: Aligning Science, Practice, and Policy to Advance Health Equity."
Olfson honored by NIMH, ACNP
Emily Olfson, MD, PhD, a fourth-year resident in the Albert J. Solnit Integrated Training Program, has been awarded the 2019 National Institute of Mental Health (NIMH) Outstanding Resident Award. Olfson also has been chosen to receive a travel award through the American College of Neuropsychopharmacology (ACNP).
Comer School Development Program at Yale Child Study Center Is Featured in Major Report
The Comer School Development Program (SDP) at the Yale Child Study Center and its work to support the whole student are cited as an exemplary approach to supporting students’ social, emotional, and academic development in a report released by a prestigious national commission.
Psychiatric disorders share an underlying genetic basis
Thomas Fernandez, MD, Assistant Professor in the Child Study Center and of Psychiatry, and Christopher Pittenger, MD, PhD, Associate Professor of Psychiatry, contributed to a paper published in Science that explores the genetic connections between disorders of the brain at a scale that far eclipses previous work on the subject.
MOMS Partnership® listed as a top 'Two-Gen' strategy in nation
Ascend at the Aspen Institute – a leader in identifying and cultivating transformational approaches to family well-being by focusing on parents and children simultaneously – released a report June 14 that identifies the MOMS Partnership® as one of the most effective two-generation interventions in the country.
Fernandez appointed to Health and Human Services panel
Thomas V. Fernandez, MD, Assistant Professor in the Child Study Center and of Psychiatry, has been appointed to serve as a member of the U.S. Department of Health and Human Services Behavioral Genetics and Epidemiology Study Section, Center for Scientific Review.